It has been confirmed that induction of caspase-3/7, cyclin D1 and proliferation index-67 (Ki-67) protein expression by CAM are probably involved in enhancing the sensitivity of HCC cells to sorafenib [37]. The gene discussed is CCND1; the disease is hepatocellular carcinoma.